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Original Article
Repertoire of Abs primed by bacteria
in gnotobiotic mice
Nailia R Khasbiullina1,2 , Nadezhda V Shilova1,
Maxim E Navakouski1, Alexey Yu Nokel1, Yuri A Knirel2,
Ola Blixt3 and Nicolai V Bovin1,4
Abstract
Innate immunity natural Abs (NAbs) execute a number of functions, including protection and surveillance. Despite active
research, the stimuli that induce the formation of NAbs are still described only hypothetically. Here, we compared
repertoires of anti-glycan Abs in the peripheral blood of mice that received per os various bacteria. The repertoires of
Abs of mice primed in this way were compared using a microarray that included about 350 glycans, as well as 150
bacterial polysaccharides. Sterile mice did not possess anti-glycan Abs. Oral inoculation of a single strain or combination
of two to four strains of bacteria, as well as putting the animals on short-term nutrition with non-sterile food, did not
contribute significantly to the formation of Abs, whereas a single gavage of digested food of non-sterile mice induced the
formation of a repertoire close to the natural ones. Interestingly, the priming with polysaccharide Ags (in a composition
of the bacterial cell envelope), that is, dominant Ags of bacteria, led to the induction of Abs against typical glycans of
mammalian glycoproteins and glycolipids (e.g. Abs of the ABH blood group system) that do not have a structural
similarity to the polysaccharides. The results support the importance of early contact with a naı¨ve immune system
with microorganisms of the environment to form a normal NAbs repertoire.
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Introduction
Innate immunity is of paramount importance at the
early stages of mammals’ development. The moment
of birth becomes a starting point of immune system
development because the conditions of the limited
Agic stimulation in utero turn into an environment
rich with Ags. Natural Abs (NAbs) as a part of
innate immunity are present in the blood of mammals
at an early age and demonstrate a stable level and rep-
ertoire throughout life.1,2
The diﬀerence between NAbs and adaptive Abs,
induced in response to Ag invasion, was ﬁrst mentioned
when the ABO blood group system was discovered.3
Since then some of the other NAbs directed to blood
group Ags, xeno-Ags and malignant cells have been
found and partly characterized.4–8
NAbs mainly belong to the IgM class, have low
aﬃnity, and are believed to be polyreactive
immunoglobulins1,7; nevertheless, some of them
demonstrate precise speciﬁcity, as mentioned above
for anti-A and anti-B. Similar to adaptive Abs, broadly
reactive NAbs protect the organism, but have a number
of distinctive features. NAbs are the ﬁrst line of defense
from infection because of their permanent presence in
the organism (without canonical immunization) and
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can respond to foreign agents much faster. In mice, a
2- to 7-d period is required to produce high-speciﬁcity
adaptive Abs – this is more than enough for infection to
spread due to the high speed of viral and bacterial
propagation. NAbs also perform the clearance of
metabolites, i.e. utilization of cell degradation products
(including the excessive or pathogenic proteins) and the
elimination of transformed cells.9–11
NAbs formation is poorly understood, despite dec-
ades of research. Several key points have been sug-
gested,12–16 particularly that NAbs appear to result
from enterobacterial stimulation. Many factors can
aﬀect the formation of Abs directly or indirectly, includ-
ing nutrition. Nutrition components are substrates for
many microorganisms that are involved in the digestion
of food and the synthesis of vital compounds. A normal
microbiota is required for defense against pathogens by
competing for limited resources. In the presence of
normal microﬂora, which is relatively stable during the
lifetime and contains more than 400 species, pathogens
remain within the transient microﬂora.17,18
NAbs play an important role in childbirth, that is
during the transition from relatively sterile intrauterine
conditions to an environment rich in Ags. The ﬁrst days
and weeks of life represent a crucial window of oppor-
tunity for shaping the development of the gastrointes-
tinal tract and immune system, as well as for the adult
microbiota. The study of the immune system at the
level of cells and immunoglobulins in humans, espe-
cially young children, is diﬃcult not only because of
the risk of harm to health, but also because of the com-
plexity of immunity. A useful model, apparently, is that
of sterile animals whose living conditions can be con-
trolled and varied. Adjusted for obvious diﬀerences
between the human and mouse organisms, the results
can be informative and useful. Little information about
NAbs in mice is available, despite the fact that NAbs’
producers (B1 cells) were ﬁrst discovered and charac-
terized in mice,19 particularly data on Abs directed to
auto-Ags (DNA, proteins, membrane oxidation-caused
epitopes).20–22 To our knowledge, a systematic study of
the anti-glycan Abs repertoire in mice has not been
carried out yet. Presumably, as in humans, the murine
repertoire of anti-glycan Abs is broad, because the
environmental conditions (microbiota and nutrition)
are similar to those of humans.
In this study, we challenged sterile mice with bacteria
per os, and examined the speciﬁcity and comprehensive-
ness of the raised repertoires of Abs that are believed to
be NAbs.
Materials and methods
Serum samples
The repertoire of anti-glycan Abs in sera of male Swiss
Webster mice at the age of 3–4mo was studied.
Animals were obtained by Cesarean section and
housed in special isolators as described previously.23
Each group (see Supplement 1) of animals included
four mice. Group #1: sterile conditions were kept;
group #2: contact to Escherichia coli K-12 strain W
3110; group #3: contact to Biﬁdobacterium longum
strain NCC2705 (Nestec Ltd., Nestle´ Research Center
Lausanne, P.O. Box 44, CH-1000 Lausanne 26); group
#4: contact to Bacteroides thetaiotaomicron strain VPI-
5482 (ATCC 29148); group #5: contact to Lactobacillus
reuteri strain SD2112 (ATCC 55730); group #6: contact
to four strains of bacteria (E. coli strain W3110,
B. longum strain NCC2705, B. thetaiotaomicron strain
VPI-5482, L. reuteri strain SD2112); group #7: trans-
ferred to normal diet (standard granulated food); group
#8: gavaged orally with a sample of non-sterile mice
feces; group #9: conventional controls, CD-1 male
mice fed with standard granulated food.
All mice from groups #1–6 were fed with sterilized
food (autoclaved chow diet, LabDiet).
Mice from groups #2–5 were given a single 200-ml
dose (108 CFU/mouse) of an overnight bacterial cul-
ture. Conventional controls were born normally and
reared with their mothers until 9–14wk of age. Blood
samples were obtained 28 d after the exposure in all
experiments. Animals were handled in strict accordance
with good animal practice as deﬁned by the relevant
local animal welfare bodies; all animal procedures
were supervised and approved by Food for Health
Science Centre, Lund University ethics committee for
animal experimentation.
Environmental endotoxins were not tested in the
material used to prime Abs.
Microarray chips
Microarrays were prepared from 341 diﬀerent synthetic
amine-functionalized glycans and 146 bacterial polysac-
charides, using N-hydroxysuccinimide-derivatized glass
slides (slide H, Schott-Nexterion, Mainz, Germany), as
described previously.24 The glycan library included
blood group Ags and some of the most frequently
occurring terminal oligosaccharides, as well as core
motifs of mammalian N- and O-linked glycoproteins
and glycolipids, tumor-associated carbohydrate Ags
and polysaccharides from pathogenic bacteria.
Synthetic glycan structures (> 95% purity) are struc-
turally the same as natural ones. Their structures,
NMR data of polysaccharides and related references
are available at http://csdb.glycoscience.ru/bacterial
(Zelinsky Institute of Organic chemistry, Moscow,
Russia). The glycans (50mM solutions) and polysac-
charides (10mg/ml) were printed in 6–12 replicates.
A complete list of printed glycans can be found in the
supplementary material (see Supplement S2). Two
chips from each batch were analyzed using standard
Complex Immunoglobulin Preparation (CIP,
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Immunogem, Russia) at a concentration of 1mg/ml
with biotinylated goat-anti-human Abs (Thermo
Fisher Scientiﬁc, USA) at a concentration of 10 mg/ml
followed by Streptavidin Alexa Fluor 555 Conjugate
(Thermo Fisher Scientiﬁc, USA) at a concentration of
1 mg/ml. Batches of printed microarrays with intra- and
inter-chip correlation more than 0.9 were used.
After printing, microarrays were blocked for 90min
at 25C with blocking buﬀer (100mM boric acid,
25mM ethanolamine plus 0.2% (v/v) Tween 20
(Sigma-Aldrich, St. Louis, MO, USA), pH8.5), which
was then washed out with milli-Q grade water and dried
by the air. Blocked microarrays were stored at –20C
for further analysis.
Before serum analysis, microarrays were incubated
in an incubation chamber for 15min at 25C with PBS
plus 0.1% (v/v) Tween-20 (buﬀer 1) (Sigma-Aldrich, St.
Louis, MO, USA), and the buﬀer was then carefully
removed from the microchip surface using Whatman
ﬁlter paper (Sigma-Aldrich, St. Louis, MO, USA).
Mouse sera were diluted (1:30) in PBS plus 1% (w/v)
BSA (Sigma-Aldrich, St. Louis, MO, USA) and 0.1%
(v/v) Tween-20 (buﬀer 2). Diluted serum was spread
over the slide surface and incubated with agitation
(32–36 rpm) at 37C for 1.5 h. After a round of washing
steps with buﬀer 1, buﬀer 3 (PBS with 0.001% v/v
Tween-20) microarrays were then incubated for 1 h at
37C (32–36 rpm) with goat anti-mouse IgG+IgM
(H+L) conjugated to biotin (Thermo Fisher
Scientiﬁc, Waltham, MA, USA) at a concentration of
10 mg/ml in PBS plus 1% BSA and 0.1% Tween-20
(buﬀer 2). The unbound fraction was removed by
repeating the same round of washing steps.
Microarrays were incubated in darkness at 25C for
45min (32–36 rpm) with streptavidin labeled with
Alexa555 dye (Thermo Fisher Scientiﬁc, Waltham,
MA, USA) at a concentration of 1 mg/ml. After
another round of washing (plus using milli-Q grade
water at the ﬁnal stage), the microarrays were dried
by airﬂow. The microarrays were scanned using
ScanArrayGx scanner (PerkinElmer, USA) using the
excitation wavelength 543 nm. The obtained data were
processed using ScanArray Express 4.0 software and
the ﬁxed 70 mm-diameter circle method as well
as Microsoft Excel software. Six to twelve spot repli-
cates represent each oligosaccharide or polysaccharide
on the array, and data are reported as median relative
ﬂuorescence units (RFU) of replicates. Median devi-
ation was measured as interquartile range. A signal
(the titer of Abs as the result of their aﬃnity and
avidity) where the ﬂuorescence intensity exceeded the
background value by a factor of ﬁve was considered as
signiﬁcant.
The choice of reagents was due to our desire to catch
as many diverse Abs as possible, rather than whether
they belonged to a particular class. Considering the lit-
erature and our own experience of working with small
rodents, we did not expect to see a wide repertoire of
anti-glycan Abs.25,26 For the same reasons, data on the
repertoire of each mouse were not subjected to add-
itional statistical processing and were presented in
their original and most detailed form (see
Supplementary Table 3).
Results
Abs in the group of sterile mice unexposed
to bacteria (group #1)
No anti-glycan Abs was found in a group of mice
born and housed under sterile conditions and not
exposed to any bacteria, except for one mouse in
which serum signiﬁcant titers of Abs directed to glycans
containing Fuca1-2Gal (blood group H motif) were
observed, namely Fuca1-2Galb1-4(Fuca1-3)GlcNAcb
(LeY), Fuca1-2Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-
4Glcb (LeYhexa), GalNAca1-3(Fuca1-2)Galb1-
3GalNAca (A type 4), fucosylated polysaccharide from
E. coli O127 and also L-rhamnose (monosaccharide)
(data not shown, see Supplementary Tables 3 and 4).
Abs in groups of mice exposed to a single
bacterial strain
In the group orally inoculated with E. coli W3110
(group #2), Abs directed to Gala1-3Galb1-4(Fuca1-
3)GlcNAcb(aGalLeX) were detected in all mice; in
one mouse, Abs were observed to Fuca1-2Galb1-
4GlcNAcb (H type 2) and polysaccharide from
Proteus mirabilis O31 (data not shown). In the group
orally inoculated with B. longum NCC2705 (group #3),
Abs were detected to the ABH blood group Ags, and (a
high titer) to GlcAa1-6Gal, aGalLeX and some poly-
saccharides (Table 1).
In the group orally inoculated with B. thetaiotaomi-
cron VPI-5482 (ATCC 29148) (group #4), Abs were
observed in all animals and were mainly directed to
LacdiNAc disaccharide and its O-sulfates. There was
a high titer of Abs to P. mirabilis O31 (Table 1).
In the group orally inoculated with L. reuteri
SD2112 (ATCC 55730) (group #5), Abs were observed
to the blood group ABH Ags, L-rhamnose, glycans
containing the GalNAca-core, O-sulfated N-acetyl-lac-
tosamine and several polysaccharides (Table 1).
In the group of animals orally inoculated with a
combination of four strains of bacteria (group #6),
Abs were detected to the blood group A Ags, L-rham-
nose and polysaccharides E. coli O58, N127 and N148,
P. mirabilis O13, and Shigella dysenteriae type 7
(Table 1). It was found that the total number of positive
Ags in this group is comparable to cases where only one
bacterial strain was gavaged. Thus, such a stimulus is
apparently insuﬃcient for the formation of a mature
repertoire.
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In the group of animals fed with non-sterile food
(group #7), Abs were observed to O-sulfated LN,
O-sulfated LacdiNAc and to polysaccharides E. coli
O58, E. coli O127 and P. aeruginosa O4ac (Table 1).
The repertoire of the rise in Abs appears to be poor,
similar to previous cases, where only one or a limited
number of bacteria were gavaged.
In the group of mice gavaged only once with digested
food of mice reared under laboratory conditions (group
#8), a wide repertoire of anti-glycan Abs and the highest
Abs titers were observed. Table 2 presents glycans to
which Abs were detected, totaling 54 items. This list
includes Abs found in the aforementioned groups of
animals (ABH blood group Ags, O-sulfated LN and
LacdiNAc, L-rhamnose) and a variety of other glycans.
The number of polysaccharide-binders is also much
higher than in the case of groups gavaged with one or
four bacteria strains (Table 1).
In the group of non-sterile mice without any add-
itional challenging (group #9), anti-glycan Abs directed
to 67 oligosaccharides and 26 polysaccharides were
detected, that is, the number of primed Abs was not
signiﬁcantly higher than in the previous group,
although the repertoires were dramatically diﬀerent
(see Supplement 3 and 4). Table 2 demonstrates glycans
to which Abs were detected in at least three animals.
Table 1. Specificity of carbohydrates targeting natural Abs in the group of mice exposed to B. longum, L. reuteri, B. thetaiotaomicron, a
mixture of four strains of bacteria (B. longum, L. reuteri, B. thetaiotaomicron and E. coli) and mice put to normal food. The list of glycans
with binding signals above 1500 relative fluorescence units (RFU) is presented.
Glycan
Number of
mice showing
significant
values
of RFU Glycan
Number of
mice showing
significant
values of RFU
Group of mice exposed
to B. longum NCC 2705
Group of mice exposed to a mixture of four strains
of bacteria (E. coli W3110, B. longum NCC 2705,
B. thetaiotaomicron VPI-5482 (ATCC 29148),
L. reuteri SD 2112 (ATCC 55730))
GlcAb1-6Galb 1
Gala1-3(Fuca1-2)Galb1-3GalNAca 1 GalNAcb 3
Gala1-3(Fuca1-2)Galb1-3GalNAcb 1 Rhaa 1
GalNAca1-3(Fuca1-2)Galb1-3GalNAca 1 GalNAcb 2
GalNAca1-3(Fuca1-2)Galb1-3GalNAcb 1 (6-O-Bn-Galb1)-3(6-O-Bn)GlcNAcb 2
E. coli O58 1 GlcAb1-6Galb 1
E. coli O127 2 (GalNAcb-PEG2)3-b-Asp-Asp 3
E. coli O148 1 GalNAca1-3(Fuca1-2)Galb1-4GlcNAcb 1
Sh. dysenteriae type 1 1 GalNAca1-4(Fuca1-2)Galb1-4GlcNAcb 2
Group of mice exposed to
L. reuteri SD 2112 (ATCC 55730)
GalNAca1-3(Fuca1-2)Galb1-3GalNAca 3
Rhaa 1 E. coli O127 3
3,4-O-Su2-Galb1-4GlcNAcb 3 E. coli O148 1
GlcNAcb1-6(GlcNAcb1-4)GalNAca 1 P. mirabilis O13 1
GalNAca1-3(Fuca1-2)Galb1-3GalNAca 1 Sh. dysenteriae type 7 1
(GlcNAcb1)3-3,4,6-GalNAca 1 Group of mice exposed to
B. thetaiotaomicron VPI-5482 (ATCC 29148)GalNAca1-3(Fuca1-2)Galb1-3GalNAcb 1
E. coli O127 3 GalNAcb1-4GlcNAcb 1
E. coli O148 1 GalNAcb1-4(6-O-Su)GlcNAcb 1
P. mirabilis O28 1 3-O-Su-GalNAcb1-4GlcNAcb 1
P. mirabilis O31 1 6-O-Su-GalNAcb1-4GlcNAcb 1
Sh. dysenteriae type 1 1 3,6-O-Su2-GalNAcb1-4GlcNAcb 3
Group of mice put to non-sterile food 6-O-Su-GalNAcb1-4(6-O-Su)GlcNAcb 2
3,4-O-Su2-Galb1-4GlcNAcb 1 GlcNAcb1-6(GlcNAcb1-4)GalNAca 1
3-O-Su-GalNAcb1-4GlcNAcb 1 GlpNAcb1-4(Fuca1-6)GlcNAcb 1
3,6-O-Su2-GalNAcb1-4GlcNAcb 2 (GlcNAcb1-4)6 1
E. coli O58 1 E. coli O127 1
E. coli O127 1 P. mirabilis O31 3
P. aerginosa O4ac 1
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Discussion
Sterile mice allow us to study the genesis of natural
Abs and directly observe their formation as a response
to stimuli that mimic natural ones. The printed glycan
array technology revealed that, as expected, in mice
housed in conditions excluding living bacteria (group
#1), no Abs was found against oligosaccharides and
bacterial polysaccharides, whereas serum of mice
housed in natural environment (group #9) contains
Abs at least to 93 glyco-ligands (in the 500-ligand
array). It was found that sterile mice acquire an
almost complete repertoire of anti-glycan NAbs if
they once were gavaged with a ‘library’ of Ags repre-
senting the full range of mice microbiota (group #8).
A signiﬁcant number of speciﬁcities thus primed shared
with the regular repertoire of non-sterile animals
(Table 3). When mice were inoculated by the oral
route with only one or a few individual bacteria strains,
the number of emerged Abs was small.
The result of exposure to a combination of four bac-
teria was not the ‘‘sum’’ of four single-bacteria
repertoires (groups #2–6). Notably, speciﬁcity of the
Abs does not correspond to the chemical structure of
Ags in the composition of the bacteria; indeed, Abs dir-
ected to ABH blood group Ags are observed, although
there is no bacterial blood group related glycoproteins
or glycolipids, and their polysaccharides do not contain
closely or even remotely related structures.25 And vice
versa: LOS of E. coli W3110, used for the oral inocula-
tion, has the (complete) structure GlcNAcb1-7Hep1-
6Glca1-2Glca1-3(Gala1-6)Glcb-inner core (in which
Hep stands for L-glycero-D-manno-heptopyranose, or
other variants, that is, Hepa1-6Glca1-2Glca1-
3(Gala1-6)Glcb-inner core and Glca1-2Glca1-3(Gala1-
6)Glcb-inner core). This bacterium does not promote
production of Abs to partial oligosaccharides of its
full structure such as GlcNAcb1-X or Gala1-6Glcb.
The priming of Abs formation in animals having
standard nutrition (group #7) leads to the appearance
of a poor repertoire (about 10 glycans) of Abs; further-
more, these are not in the top-rank Abs found in non-
sterile animals (group #9) (Table 1). This observation
Table 2. Specificity of carbohydrates targeting natural Abs in the group of mice orally gavaged with a sample of non-sterile mice feces
(left columns, ligands positive for at minimum two of four mice are shown; total amount of glycans to which Abs were detected is 54,
see Supplementary Table 1) and non-sterile, conventional mice (right columns, only ligands positive for at minimum three of four mice
are shown; total amount of glycans to which Abs were detected is 93, see Supplementary Table 1). The list of glycans with binding
signals above 1500 relative fluorescence units (RFU) is presented.
Group of mice orally gavaged with a sample of
non-sterile mice feces Group of non-sterile mice
Glycan/bacterial strain
Number of
mice showing
significant values
of RFU Glycan/bacterial strain
Number of
mice showing
significant
values of RFU
GlcNAcb1-4GlcNAcb 3 3-O-Su-GlcNAcb 4
Gala1-3(Fuca1-2)Galb1-3GalNAca 2 6-Bn-Galb1-4GlcNAcb 4
Gala1-3Galb1-4(Fuca1-3)GlcNAcb 2 (6-O-Bn-Galb1)-3(6-O-Bn)GlcNAcb 3
Fuca1-2Galb1-3GalNAca 4
GalNAca1-3(Fuca1-2)Galb1-3GalNAcb 3 GlcNAcb1-3Galb1-4GlcNAcb 3
GlcNAcb1-3Galb1-4GlcNAcb 3
GalNAca1-3(Fuca1-2)Galb1-3GalNAca 2 Galb1-4Galb1-4GlcNAcb 3
Gala1-3(Fuca1-2)Galb1-3GalNAca 3
(GlcNAcb1-4)6 3 Galb1-3GlcNAca1-6Galb1-4GlcNAcb 3
S. enterica O13 2 Galb1-3GlcNAcb1-6Galb1-4GlcNAcb 3
S. enterica O67 3 Galb1-4GlcNAca1-6Galb1-4GlcNAcb 4
S. enterica O41 2 Galb1-4GlcNAcb1-6Galb1-4GlcNAcb 3
E. coli O58 4 GalNAca1-3(Fuca1-2)Galb1-3GalNAca 4
E. coli O127 4 GalNAca1-3(Fuca1-2)Galb1-3GalNAcb 4
E. coli O148 3 Fuca1-2Galb1-3GlcNAcb1-3Galb1-4GlcNAcb 3
E. coli O14 2 S. enterica O13 4
E. coli O19ab 2 E. coli O58 4
P. aerginosa O9ad 2 E. coli O127 4
Sh. dysenteriae type 1 3 E. coli O14 3
Sh. flexneri type 6 2 Sh. dysenteriae type 1 3
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shows the insuﬃciency of that set of antigenic stimuli
that is present in the nutrition components as such, as
well as those belonging to the killed (autoclaved) bac-
teria – if they were present in the food. Unexpectedly,
no identical Ab repertoires were observed for animals
orally inoculated with identical bacteria in the same
conditions (groups #2–6); this is true for all studied
groups, including mice gavaged with feces (group #8),
that is, when we observed the highest number of NAbs.
This is an astonishing phenomenon. Apparently, apart
from the dictates of both identical genetics and the
same conditions, the repertoire of the Abs partially
has a stochastic component. Notably, this is consistent
with previous data demonstrating non-identical NAb
repertoires in a-galactosyltransferase-knock-out
BALB/c mice housed together,27,28 but is contradictory
to the publication in which three Ags were reported to
ostensibly have primed their cognate NAbs.29
However, the immature repertoire can be diﬀerent in
certain animals (individuals), and here the principle
‘ﬁrst come ﬁrst served’ as regards to the encounter of
B1 cells with bacteria works. The lack of compliance
between speciﬁcity of challenged Abs to the structure of
administered Ags is easily explained in terms of the key
role of bacteria in the formation of B1 cell immunity.
Antigen mimicry is well known for B2 cell immu-
nity,30–32 i.e. for the production of speciﬁc high aﬃnity
Abs. B1 cells generally produce a polyreactive low aﬃ-
nity Abs, therefore the phenomenon of mimicry is more
‘‘easily allowed’’ and thus expected to be more
common. In particular, human NAbs against blood
group A and B antigen bind to bacterial polysacchar-
ides having no any similarity to these antigens, a large
number of other examples can be found in the
literature.33
Why are B1 cells primed with bacterial but not primed
with self Ags at an early stage of development? The role
of TLRs (of B1 lymphocytes) in establishment of natural
Abs is well documented;34 we believe that the trigger
function of bacteria in the genesis of NAbs is stipulated
by co-localization of Agic determinant with TLR ligands
– this promotes the formation of an immuno-synapse35
followed by activation of the B1 cell. Before birth, the
organism’s ability to prime B1 cells with bacteria is very
limited, so it has virtually no NAbs (or there are none at
all, as is the case with the model of sterile animals).
Immediately after birth, active occupation of intestine
by microorganisms favors the formation of the NAbs
repertoire, including Abs to bacteria, self-proteins, allo-
and xeno-Ags, tumor-associated epitopes, anionic poly-
mers (DNA, GAGs) and other Ags. In other words, we
believe that the total repertoire of NAbs is provided
exclusively by microorganisms from a normal micro-
biota. Although it is not known how many orally admi-
nistrated antigens reach the mouse digestive tract and
pass the mucin/endothelial cells barriers to reach immu-
nocompetent cells, there are assumptions according to
which we could suggest that M cells (in Payer’s patches)
evaluate the intestinal lumen environment and transport
bacteria through the epithelial barrier to sub-mucosal
macrophages and dendritic cells, which then act as anti-
gen-presenting cells. This process, called ‘bacterial trans-
location’, is well described in sterile animals, as well as
prematurely born mice and children, characterized by
underdevelopment or imperfection of the mucin
layer.35–41
In our work, we can assume (but not aﬃrm) that all
or a major part of the anti-glycan Abs we identiﬁed are
related to NAbs, because of two main reasons that we
consider most important. First, Abs emerge as a
response to oral contact with a source of a potential
Ag in a relatively short time, which is unlikely with an
adaptive immune response. Second, we see a structural
discrepancy between the speciﬁcity of the observed Abs
and Ags, whereas in the case of adaptive Abs this struc-
tural similarity underlies the speciﬁc immune response.
The following conclusions can be drawn.
1. Sterile animals, reliably deprived of the possibility of
contact with microorganisms, have little or no anti-
glycan Abs.
Table 3. Glycans that bound Abs in the sera of non-sterile mice
as well as mice orally gavaged with feces of non-sterile, conven-
tional mice.
Rhaa
ManNAcb
GlcNAcb1-3GalNAca
GlcNAcb1-4GlcNAcb
GlcNAcb1-6(GlcNAcb1-4)GalNAca
Galb1-4Galb1-4GlcNAcb
(GlcNAcb1)3-3,4,6-GalNAca
GalNAca1-3(Fuca1-2)Galb1-3GalNAca (blood group A)
GalNAca1-3(Fuca1-2)Galb1-3GalNAcb (blood group A)
E. coli O14: Gala1-2Gala1-2(Galb1-4)Glca1-3Glca1-inner core-
lipid A
E. coli O58: -[4(R-Lac2-3Rhap2Aca1-3)Manb1-4Mana1-
3GalNAcb1]n-
E. coli O127: -[2Fuc3(65%)Ac4(35%)Aca1-2Galb1-3GalNAca1-
3GalNAca1]n-
E. coli O148: -3[Rhaa1-3Rhaa1-2Glca1-3GlcNAca1]n-
P. mirabilis O13: -[4(Lys2-6)GalAa1-4Gala1-3(Ser-(2-
6)GalA4Aca1-3GlcNAcb1]n-
P. mirabilis O31: -[3LQuiNAca1-3GlcNAca1-6(S-Lac-1-
3)GlcNAca1]n-
S. enterica O13: -[2Fuca1-2Galb1-3GalNAca1-3GlcNAca1]n-
(blood group H)
Sh. boydii type 17: -[6(R-Lac2-4)Glcb1-4GalNAca1-
3GalNAcb1]n-
Sh. dysenteriae type 1: -[3Rhaa1-3Rhaa1-2Gala1-3GlcNAca1]n-
Sh. dysenteriae type 7: -[GalNAcA3Ac6NH2a1-4GalNAcAa1-
3GlcNAc]n-
Sh. flexneri type 6b: -[2Rha3(60%)Ac4(30%)Aca1-2Rhaa1-
4GalAb1-3GalNAcb1]n-
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2. Contact with a small number of bacterial strains
belonging to the normal microﬂora stimulates
(primes) in mice production of anti-glycan Abs; their
level and variety are dramatically inferior to Abs of
mice living under standard non-sterile conditions.
3. An almost comprehensive repertoire of anti-glycan
NAbs is formed as a result of single gavage of
digested food of non-sterile animals.
4. The observed priming with bacteria leads to the
appearance of Abs directed not only to bacterial
polysaccharides, but also to typical glycans of
mammal glycoproteins/glycolipids having no distinct
structural similarity with bacterial polysaccharides.
Specifying the hypothesis of Springer et al.12 (i.e. the
appearance of NAbs as a result of the structural
similarity of bacterial polysaccharides with mamma-
lian glycans), we explain this phenomenon not by the
direct structural similarity of ABH oligosaccharides
and bacterial polysaccharides, but by molecular
mimicry when the epitope is a spatial glycotope, a
protein epitope or a molecular pattern.
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